YouTube Videos Spotify Podcasts Apple Podcasts Trusted by 500,000+ researchers, students, and professionals
it doesn't prove them
Its active ingredient is semaglutide, which is a GLP-1 receptor agonist (GLP-1 RA)
7:45 AM: Eat breakfast
Ideal candidates for semaglutide include: Adults with type 2 diabetes (Ozempic and Rybelsus) Adults who have established heart and blood vessel-related disease or those who are at risk of developing these diseases or heart failure (Ozempic) Adults with chronic kidney disease and type 2 diabetes, to reduce the risk of worsening kidney disease or end-stage renal disease (Ozempic) Children aged 12 or more, adolescents, and adults with obesity (BMI 30 or more) and overweight (BMI 27 or more) with at least one weight-related complication, such as hypercholesterolemia, hyperlipidemia, heart disease, and hypertension (Wegovy) Patients with metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver scarring or fibrosis, but they should not have cirrhosis (Wegovy) Head-to-head comparison: Metformin vs

GLP-1 was discovered in the 1980s, and GLP-1RAs have been around for about 20 years (the first one approved for humans was a synthetic version of a molecule isolated from the venom of Gila monsters), but recent development of new versions of this type of drug are revolutionising treatment of diabetes and obesity